Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 12, 1996

View Archived Issues

New antiviral agents from CNRS

New hypolipidemic agents claimed by Janssen

Positive GABAA receptor complex modulators claimed

Tyrosine kinase inhibitors described by Pharmacia & Upjohn

MMP/TNF inhibitors reported by Pfizer

New antidepressant compounds in development at HMR

Novel dual-action compounds described by Abbott

NOS inhibitors described by Searle

Italian researchers described novel anti-HIV compounds

Daiichi claims LTD4 antagonists for treating allergic diseases

Drugs quicker to reach market in U.S. than in Germany and Japan

EchoGen Emulsion initial trial results in prostate disease revealed

GastroMARK approved for marketing by FDA

hu1124 advances to clinical studies

Millennium/Lilly's gene-based assay for atherosclerosis

Janssen files for lower-dose risperidone in U.S.

Procept's topical microbicide enters phase I in Europe

Boehringer Mannheim markets HGV diagnostic developed under collaboration with Genelabs

Mitsubishi Chemical isolates novel antitumor agent from plant source

New antitumor agents from Kyowa Hakko

NMDA antagonists ameliorate ototoxicity of aminoglycoside antibiotics

CEPRATE SC approved for marketing in U.S.

VISX supplemental PMA slated for review

Company Profile: Aurora Biosciences

Positive clinical results reported for MDX-22 in AML patients

Favorable phase I/II data presented for Xoma's Neuprex as pediatric meningococcemia treatment

Positive clinical results for Targretin reported at ASH meeting

NAVA-Chiron Behring vaccine distribution agreement signed

Cellcor, Neoprobe sign RIGS/ACT manufacturing agreement

Oncor issued U.S. patent on technology for early detection of breast cancer

Biogen, Creative BioMolecules to codevelop drugs for renal disorders

First approval for Pharmacyclics' MRI contrast agent

Bristol-Myers Squibb and NIH continue Taxol collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026